Ask AI
ProCE Banner Activity

My Thoughts on Hemophilia Studies From ASH 2020 With Direct Impact on Patient Care

Clinical Thought
Get an expert’s thoughts on key data most likely to affect care of patients with hemophilia presented at ASH 2020.

Released: December 18, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Sanofi Genzyme Corp

Takeda Pharmaceutical Co Ltd

Faculty Disclosure

Primary Author

Stacy E. Croteau, MD, MMS

Director Hemophilia/VWD Program
Boston Children's Hospital
Medical Director
Boston Bleeding Disorders Center
Assistant Professor of Pediatrics
Harvard Medical School
Boston, Massachusetts

Stacy E. Croteau, MD, MMS, has disclosed that she has received consulting fees from Bayer, Biomarin, CSL-Behring, and Pfizer and funds for research support from Novo Nordisk and Spark Therapeutics.